AGMB
AgomAb TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
AGMB vs peer average
32/100
AGMB vs. peer average (D vs. C)
Grade spread
A 2 · B 1 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
CBIO is the first available peer comparator.
Similarly sized same-sector candidate in the packet; no direct indication or asset overlap was verified, so it is only a loose risk and valuation reference.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AGMB
AgomAb Therapeutics
CBIO
Crescent Biopharma
Grade
D
D
Momentum
70
73
Value
46
41
Sentiment
52
55
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs CBIO
AGMB / CBIO
Grade Position
Below peers
AGMB vs. peer average (D vs. C)
32/100
Momentum
70
CBIOValue
46
AGMBSentiment
52
CBIORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AGMB
CBIO is the first peer returned for this comparison set.

